Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05674552
PHASE2/PHASE3
Exogenous Ketone Esters for Refractory Status Epileptics
Sponsor: Sohag University
View on ClinicalTrials.gov
Summary
This study aims to investigate the efficacy of add-on exogenous ketone esters for the treatment of children with refractory generalized convulsive status epilepticus
Official title: Efficacy of Exogenous Ketone Esters for Children With Refractory Convulsive Status Epileptics
Key Details
Gender
All
Age Range
1 Year - 10 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-01-10
Completion Date
2025-07-01
Last Updated
2024-11-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
Exogenous ketone ester
500 mg/kg over 5 min administered by nasogastric tube, followed after 1 hr by repeated hourly doses of 125 mg/kg for 8 hrs.
Locations (1)
Department of Pediatrics at Sohag University Hospital
Sohag, Egypt